Guardian Pharmacy Services, Inc.

GRDNNYSEHealthcare● Active

$40.51

+$0.03(+0.07%)

Market Cap$2.6B

P/E Ratio—

52W High$41.36

52W Low$19.17

Avg Volume492K

Open$40.60

Beta0.08

PE Ratio Market Cap Forecast

Guardian Pharmacy Services, Inc. (GRDN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

grdn · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Guardian Pharmacy Services, Inc. (GRDN) measures how much investors pay for each dollar of the company's trailing earnings. GRDN's current PE ratio of 48.44x is calculated by dividing its stock price of $40.51 by its TTM earnings per share of $0.84. +12.7% elevated vs 5Y avg 43.0x

48.44x

P/E Ratio (TTM)+12.7%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E

32.15x

FY2026 est. EPS $1.26

Based on 4 analysts

EPS (TTM)

$0.84

TTM · diluted EPS

PEG Ratio

0.23

Below 1.0 · Growth adjusted

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Guardian Pharmacy Services, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2018 – 2025 · Annual

PE Ratio (TTM)

5Y Avg 43.0x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 7 fiscal years · Front-end computed

Average

46.6x

7-yr mean

Median

44.8x

7-yr midpoint

Minimum

27.5x

Lowest year

Maximum

66.3x

Highest year

48.4x ← Now

27.5x
MinQ1 · 25%44.8x
MedianQ3 · 75%66.3x
Max

Within Historical Range

At 48.44x, GRDN's current P/E is within its average historical range over the past 7 fiscal years.

57th percentileHigher than 4 of 7 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Distribution · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Guardian Pharmacy Services, Inc.You GRDN	$2.6B	48.44x	+237.5%	$0.84
Edgewise Therapeutics, Inc. EWTX	$3.7B	N/A	—	-$1.63
Janux Therapeutics, Inc. JANX	$824M	N/A	—	-$1.83
Pediatrix Medical Group, Inc. MD	$1.8B	11.03x	-23.2%	$1.94
Mesoblast Limited MESO	$1.8B	N/A	—	-$0.85
National HealthCare Corporation NHC	$2.9B	17.67x	+23.2%	$7.76
Nuvation Bio Inc. NUVB	$1.7B	N/A	—	-$0.60
Industry Average 2 peers with valid PE	—	14.35x	baseline	—

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-12-31Latest FY2025	38.14x	$0.79	—
2024-12-31 FY2024	—	$-1.41	—
2023-12-31 FY2023	40.73x	$0.39	+48.2%
2022-12-31 FY2022	27.48x	$0.58	-53.9%
2021-12-31 FY2021	59.67x	$0.27	+22.2%
2020-12-31 FY2020	48.81x	$0.33	+9.0%
2019-12-31 FY2019	44.77x	$0.36	-32.5%
2018-12-31 FY2018	66.32x	$0.24	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $40.51 ÷ $0.84 = 48.44x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

GRDN pe ratio · 6 questions

GRDN's current PE ratio is 48.44x as of 2026-06-08, based on a stock price of $40.51 and TTM EPS of $0.84. Data sourced from Financial Modeling Prep via GRDN's SEC 10-K and 10-Q filings.

GRDN PE ratioWhat is GRDN PE ratioCurrent PE ratio of GRDNGRDN PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Guardian Pharmacy Services, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08